Human parvovirus 4 (PARV4, family Parvoviridae, genus Tetraparvovirus) displays puzzling features, such as uncertain clinical importance/significance, unclear routes of transmission, and discontinuous geographical distribution. The origin, or the general reservoir, of human PARV4 infection is unknown. We aimed to detect and characterize PARV4 virus in faecal samples collected from two wild chimpanzee populations and 19 species of captive non-human primates. We aimed to investigate these species as a potential reservoir and alternate route of transmission on the African continent. From almost 500 samples screened, a single wild Pan troglodytes schweinfurthii sample tested positive. Full genome analysis, as well as single ORF phylogenies, confirmed species-specific PARV4 infection.
Human parvovirus 4 (PARV4, genus Tetraparvovirus, family Parvoviridae) displays puzzling features, such as uncertain clinical importance/significance, unclear routes of transmission, and discontinuous geographical distribution. The first primate tetraparvovirus probably emerged in the 1980s together with the appearance of human immunodeficiency virus (HIV) infection [1] , and, so far, three phylogenetically distinct genotypes have been described in humans. Since the first description of human PARV4 in 2005, the amount of epidemiology data has grown and has been reviewed recently by Matthews et al. [2] . Human PARV4 G1 and G2 are predominant in Europe, North America and the Middle East [3] [4] [5] [6] [7] [8] [9] [10] and are most often found in patients with a history of parenteral drug application who are suffering from HIV, hepatitis C virus or hepatitis B virus infections [10, 11] . Genotype 2 has also been reported in Asia [6, 12] . Human PARV4 G3 is distributed across Africa [13, 14] and exhibits unique features of transmissibility. It has been detected in diverse cohorts in the absence of other bloodborne viruses and/or intravenous drug/therapy application history [13] [14] [15] [16] , suggesting a transmission route other than parenteral infection. High frequencies of seropositivity in wild chimpanzee and gorilla serum samples also support the existence of another route of transmission of tetraparvoviruses in Africa [17] .
The origin, or the general reservoir, of human PARV4 is unknown. Three independent transmission events, perhaps 1 3 from chimpanzees or other primate species, could be the source of the three genotypes in humans [1, 17] . A limited number of sequenced non-human primate tetraparvoviruses have been found to be species-specific for chimpanzees and colobus monkeys [17, 18] . Despite evidence of frequent exposure of African hunters to non-human primate bush meat, no direct evidence of cross-species parvovirus transmission has been found [18] .
All previously described tetraparvovirus sequences from non-human primates (NHPs) were obtained from either blood or bush meat samples [17, 18] . Our aim was to detect and characterize tetraparvoviruses in fecal samples collected from chimpanzees and other NHPs with different levels of contact with humans, based on samples from (i) a wild, non-habituated eastern chimpanzee population in Issa Valley (Tanzania), known to be simian immunodeficiency virus (SIV) positive [19] , (ii) a wild, habituated eastern chimpanzee population from Kalinzu Forest Reserve (Uganda), and (iii) captive African non-human primates from Czech and Slovak zoos.
In total, 202 unidentified faecal samples were collected from eastern chimpanzees with very limited contact with humans, in the Issa Valley (Fig. 1) in Tanzania (between March 2012 and November 2013). The study site comprises approximately 100 km 2 and is one of the driest and most open chimpanzee habitats, situated east of Lake Tanganyika, in western Tanzania [20] . The population density of Issa chimpanzees is estimated to be ~0.25 individuals/ km 2 [21] . Further faecal samples (in total 123, 1-10 per individual) were collected from 42 identified individual habituated eastern chimpanzees (20 males, 22 females) with daily distant contact with researchers in the Kalinzu Forest Reserve (Fig. 1 ) [22] during April-July 2014. The forest reserve (~137 km 2 ) is one of the three largest forest blocks in Uganda and is located on the eastern ridge of the western Rift Valley. The chimpanzee population density is estimated to be ~1.67 individuals/km 2 [23] . Captive primates with daily intensive contact with keepers were sampled in 13 Czech and Slovak zoological gardens; 25 Pan troglodytes, 10 Gorilla gorilla and 118 faecal samples from 17 different other African primate species were obtained [24] (see Supplementary Material).
All faecal samples were preserved in RNAlater TM (Ambion Inc., Austin, TX) and stored at −80 °C until further use. DNA was isolated using a PSP ® Spin Stool DNA Kit (Stratec, Germany) according to manufacturers' instructions. DNA was screened by nested PCR based on a protocol published by Sharp et al. [17] . PCR products of the expected length of 295 nt were gel purified using a QIAquick Gel Extraction Kit (QIAGEN, Germany) according to manufacturers' instructions, cloned into a pGEM ® -T Easy Vector System (Promega, USA) and sequenced by Macrogen capillary sequencing services (Macrogen Europe, The Netherlands). Additional sets of primers located in conserved parts of primate tetraparvovirus and other tetraparvovirus genomes were designed to overlap each other. PCR products were purified and cloned and both strands sequenced as described above.
All the sequences that were obtained were carefully edited using Geneious 11.0.2 [25] and compared with those available in the GenBank database using the BLASTn algorithm (http://blast .ncbi.nlm.nih.gov/Blast .cgi). Sequence alignments were generated using the ClustalW algorithm. Phylogenetic trees were inferred by the maximum-likelihood method using IQ-TREE v. 1.6.beta4 [26] . A best-fit evolution model was then chosen based on the Bayesian information criterion (BIC) computed by ModelFinder [27] . Branch support was assessed using the ultrafast bootstrap (UFBoot) approximation [28] and the SH-like approximate likelihood ratio test (SH-aLRT) [29] . For more details of the methods used, see Supplementary Material.
A total of 478 faecal samples were screened by nested PCR. Only a single sample from P. t. schweinfurthii (labelled U55) originating from the Issa Valley was found to be tetraparvovirus positive. A nearly complete U55 parvovirus genome sequence of 4955 nt in length was determined (accession no. MH215556). The U55 chimpanzee PARV4 genome contains two major open reading frames (ORFs) and two additional small ORFs (ARF1 and 2) of unknown function that are not observed in other members of the family Parvoviridae [14, 30] . The first major ORF of 1992 nt in length (U55 position 59-2050) is located at the 5′ end of the genome and encodes the non-structural protein NS1. The second major ORF is located at the 3′ end of the genome and consists of 2745 nucleotides (positions 2147-4891), encoding two structural VP proteins (914 and 552 amino acids). Following the current criteria of the International Committee on Taxonomy of Viruses, the U55 isolate belongs to the species Primate tetraparvovirus 1 (with 91.3-98.8% amino acid sequence identity in the NS1 protein to human and chimpanzee genotypes within this species, Table 1 ).
In our phylogenetic analysis, the U55 sequence clusters together with other chimpanzee PARV4 sequences obtained from wild chimpanzees, P. t. troglodytes in Cameroon [17] and P. t. verus in Côte d'Ivoire [18] , in both the NS1 (Fig. 2) and VP genes as well as in whole-genome analysis (Supplementary Material). This chimpanzee PARV4 clade is situated as a close outgroup to the human genotypes with strong bootstrap support in all analyses (Fig. 2 , Supplementary Material). Published sequences of isolates from colobus monkeys [18] formed separate clusters that were distinct from both the human and chimpanzee PARV4 viruses. To analyze the chimpanzee PARV4 genome further, we performed a recombination analysis using Simplot software with reference strains of all human PARV4 genotypes and non-human primate PARV4 isolates other than chimpanzees. The analysis revealed no potential recombination sites that could have given rise to the novel chimpanzee PARV4 tetraparvovirus (data not shown).
Our study was inspired by growing evidence of alternate routes of transmission for PARV4 in sub-Saharan Africa [30] [31] [32] . Here, we show that virus shedding is detectable in faeces through the detection of chimpanzee tetraparvovirus DNA in a single faecal sample collected from wild chimpanzees (P. t. schweinfurthii) from an SIV-positive community in the Issa Valley (Tanzania). The low positivity rate observed within the Issa chimpanzee community can be explained by the combined influence of a low amount of excreted virus (detected only by nested, not simple PCR protocols) and a limited time of shedding of the virus. Human PARV4 has been reported to be detected in faeces in a few cases, but its shedding is probably intermittent or limited in time [13] . Detection of tetraparvoviruses in fecal samples and swabs was described previously in humans and NHPs exclusively in sub-Saharan Africa [17, 18] , suggesting either that this is a unique characteristic of virus genotypes limited to Africa or that other factors unique to Africa, e.g., co-infection with other viruses/parasites (e.g. GI helminths) affects tetraparvovirus shedding into the intestinal lumen.
The repeated presence of PARV4 in faeces is the first prerequisite for transmission by the faecal-oral route, which deserves more attention, as it implies a significant role in the spread of PARV4 infection during periods of acute infection in communities sharing territories and habitats. Phylogenetic and p-distance analyses of the chimpanzee tetraparvovirus U55 described here place it together with sequences previously derived from P. t. troglodytes [17] and P. t. verus [18] . This fact, together with the lack of recombination sites detected in the genome suggests co-evolution of chimpanzee PARV4 strains with their hosts, supporting current opinion about the host specificity of tetraparvoviruses [18] . Importantly, the existence of a chimpanzee-specific clade of PARV4 suggests that the probability of zoonotic transfer of PARV4 from chimpanzees to humans is low.
Complementary sets of blood/faecal/nasal/other samples from both humans and non-human primates would be necessary to address definitively whether alternate routes of transmission of African tetraparvovirus exist and whether there is an influence of geographically restricted factors on the epidemiology of resulting infections.
